サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1388631

世界の4価インフルエンザウイルス分割ワクチン市場：考察と予測 (2029年まで)

Global Quadrivalent Influenza Virus Split Vaccine Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 96 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の4価インフルエンザウイルス分割ワクチン市場：考察と予測 (2029年まで)
出版日: 2023年12月01日
発行: QYResearch
ページ情報: 英文 96 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、4価インフルエンザウイルス分割ワクチン (Quadrivalent Influenza Virus Split Vaccine) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 4価インフルエンザウイルス分割ワクチンの製品概要
  • 市場：タイプ別
    • 世界の4価インフルエンザウイルス分割ワクチンの市場規模成長率：タイプ別, 2018 VS 2022 VS 2029
    • 0.5mL/Tube
    • Others
  • 市場：用途別
    • 世界の4価インフルエンザウイルス分割ワクチンの市場規模成長率：用途別, 2018 VS 2022 VS 2029
    • Influenza A Virus Prevention
    • Influenza B Virus Prevention
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の4価インフルエンザウイルス分割ワクチン売上予測・予想 2018-2029
  • 世界の4価インフルエンザウイルス分割ワクチンの収益：地域別
    • 世界の4価インフルエンザウイルス分割ワクチンの収益：地域別: 2018 VS 2022 VS 2029
    • 世界の4価インフルエンザウイルス分割ワクチンの収益：地域別 (2018-2023)
    • 世界の4価インフルエンザウイルス分割ワクチンの収益：地域別 (2024-2029)
    • 世界の4価インフルエンザウイルス分割ワクチンの収益市場シェア 地域別 (2018-2029)
  • 世界の4価インフルエンザウイルス分割ワクチン売上予測・予想 2018-2029
  • 世界の4価インフルエンザウイルス分割ワクチンの販売：地域別
    • 世界の4価インフルエンザウイルス分割ワクチンの販売：地域別: 2018 VS 2022 VS 2029
    • 世界の4価インフルエンザウイルス分割ワクチンの販売：地域別 (2018-2023)
    • 世界の4価インフルエンザウイルス分割ワクチンの販売：地域別 (2024-2029)
    • 世界の4価インフルエンザウイルス分割ワクチンの販売市場シェア 地域別 (2018-2029)
  • 米国・カナダ
  • 欧州
  • 中国
  • アジア（中国を除く）
  • 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

  • 世界の4価インフルエンザウイルス分割ワクチンの販売：企業別
    • 世界の4価インフルエンザウイルス分割ワクチンの販売：企業別 (2018-2023)
    • 世界の4価インフルエンザウイルス分割ワクチンの販売市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： 4価インフルエンザウイルス分割ワクチン in 2022
  • 世界の4価インフルエンザウイルス分割ワクチンの収益：企業別
    • 世界の4価インフルエンザウイルス分割ワクチンの収益：企業別 (2018-2023)
    • 世界の4価インフルエンザウイルス分割ワクチンの収益市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： 4価インフルエンザウイルス分割ワクチンの収益 2022
  • 世界の主要企業 4価インフルエンザウイルス分割ワクチン, 業界ランキング, 2021 VS 2022 VS 2023
  • 世界の4価インフルエンザウイルス分割ワクチンの販売価格：企業別
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界の4価インフルエンザウイルス分割ワクチンの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー 4価インフルエンザウイルス分割ワクチン, 製造拠点分布と本社
  • 世界の主要メーカー 4価インフルエンザウイルス分割ワクチン, 提供製品と用途
  • 世界の主要メーカー 4価インフルエンザウイルス分割ワクチン, 業界参入時期
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界の4価インフルエンザウイルス分割ワクチンの販売：タイプ別
    • 世界の4価インフルエンザウイルス分割ワクチンの販売実績：タイプ別 (2018-2023)
    • 世界の4価インフルエンザウイルス分割ワクチンの販売予測：タイプ別 (2024-2029)
    • 世界の4価インフルエンザウイルス分割ワクチンの販売市場シェア：タイプ別 (2018-2029)
  • 世界の4価インフルエンザウイルス分割ワクチン 収益：タイプ別
    • 世界の4価インフルエンザウイルス分割ワクチンの収益実績：タイプ別 (2018-2023)
    • 世界の4価インフルエンザウイルス分割ワクチンの収益予測：タイプ別 (2024-2029)
    • 世界の4価インフルエンザウイルス分割ワクチンの収益市場シェア：タイプ別 (2018-2029)
  • 世界の4価インフルエンザウイルス分割ワクチンの価格：タイプ別
    • 世界の4価インフルエンザウイルス分割ワクチンの価格：タイプ別 (2018-2023)
    • 世界の4価インフルエンザウイルス分割ワクチンの価格予測：タイプ別 (2024-2029)

第5章 市場規模：用途別

  • 世界の4価インフルエンザウイルス分割ワクチンの販売：用途別
    • 世界の4価インフルエンザウイルス分割ワクチンの販売実績：用途別 (2018-2023)
    • 世界の4価インフルエンザウイルス分割ワクチンの販売予測：用途別 (2024-2029)
    • 世界の4価インフルエンザウイルス分割ワクチンの販売市場シェア：用途別 (2018-2029)
  • 世界の4価インフルエンザウイルス分割ワクチンの収益：用途別
    • 世界の4価インフルエンザウイルス分割ワクチンの収益実績：用途別 (2018-2023)
    • 世界の4価インフルエンザウイルス分割ワクチンの収益予測：用途別 (2024-2029)
    • 世界の4価インフルエンザウイルス分割ワクチンの収益市場シェア：用途別 (2018-2029)
  • 世界の4価インフルエンザウイルス分割ワクチンの価格：用途別
    • 世界の4価インフルエンザウイルス分割ワクチンの価格：用途別 (2018-2023)
    • 世界の4価インフルエンザウイルス分割ワクチンの価格予測：用途別 (2024-2029)

第6章 米国・カナダ

  • 米国・カナダ 4価インフルエンザウイルス分割ワクチン 市場規模：タイプ別
    • 米国・カナダ 4価インフルエンザウイルス分割ワクチンの販売：タイプ別 (2018-2029)
    • 米国・カナダ 4価インフルエンザウイルス分割ワクチン 収益：タイプ別 (2018-2029)
  • 米国・カナダ 4価インフルエンザウイルス分割ワクチン 市場規模：用途別
    • 米国・カナダ 4価インフルエンザウイルス分割ワクチンの販売：用途別 (2018-2029)
    • 米国・カナダ 4価インフルエンザウイルス分割ワクチンの収益：用途別 (2018-2029)
  • 米国・カナダ 4価インフルエンザウイルス分割ワクチン 市場規模：国別
    • 米国・カナダ 4価インフルエンザウイルス分割ワクチンの収益：国別: 2018 VS 2022 VS 2029
    • 米国・カナダ 4価インフルエンザウイルス分割ワクチンの販売：国別 (2018-2029)
    • 米国・カナダ 4価インフルエンザウイルス分割ワクチンの収益：国別 (2018-2029)
    • US
    • カナダ

第7章 欧州

  • 欧州の4価インフルエンザウイルス分割ワクチン 市場規模：タイプ別
    • 欧州の4価インフルエンザウイルス分割ワクチンの販売：タイプ別 (2018-2029)
    • 欧州の4価インフルエンザウイルス分割ワクチン 収益：タイプ別 (2018-2029)
  • 欧州の4価インフルエンザウイルス分割ワクチン 市場規模：用途別
    • 欧州の4価インフルエンザウイルス分割ワクチンの販売：用途別 (2018-2029)
    • 欧州の4価インフルエンザウイルス分割ワクチンの収益：用途別 (2018-2029)
  • 欧州の4価インフルエンザウイルス分割ワクチン 市場規模：国別
    • 欧州の4価インフルエンザウイルス分割ワクチンの収益：国別: 2018 VS 2022 VS 2029
    • 欧州の4価インフルエンザウイルス分割ワクチンの販売：国別 (2018-2029)
    • 欧州の4価インフルエンザウイルス分割ワクチンの収益：国別 (2018-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 中国

  • 中国の4価インフルエンザウイルス分割ワクチン 市場規模
    • 中国の4価インフルエンザウイルス分割ワクチン 売上 (2018-2029)
    • 中国の4価インフルエンザウイルス分割ワクチン 収益 (2018-2029)
  • 中国の4価インフルエンザウイルス分割ワクチン 市場規模：用途別
    • 中国の4価インフルエンザウイルス分割ワクチンの販売：用途別 (2018-2029)
    • 中国の4価インフルエンザウイルス分割ワクチンの収益：用途別 (2018-2029)

第9章 アジア（中国を除く）

  • アジア地域 4価インフルエンザウイルス分割ワクチン 市場規模：タイプ別
    • アジア地域 4価インフルエンザウイルス分割ワクチンの販売：タイプ別 (2018-2029)
    • アジア地域 4価インフルエンザウイルス分割ワクチン 収益：タイプ別 (2018-2029)
  • アジア地域 4価インフルエンザウイルス分割ワクチン 市場規模：用途別
    • アジア地域 4価インフルエンザウイルス分割ワクチンの販売：用途別 (2018-2029)
    • アジア地域 4価インフルエンザウイルス分割ワクチンの収益：用途別 (2018-2029)
  • アジア地域 4価インフルエンザウイルス分割ワクチンの販売：地域別
    • アジア地域 4価インフルエンザウイルス分割ワクチンの収益：地域別: 2018 VS 2022 VS 2029
    • アジア地域 4価インフルエンザウイルス分割ワクチンの収益：地域別 (2018-2029)
    • アジア地域 4価インフルエンザウイルス分割ワクチンの販売：地域別 (2018-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド

第10章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカの4価インフルエンザウイルス分割ワクチン 市場規模：タイプ別
    • 中東, アフリカ ・ラテンアメリカの4価インフルエンザウイルス分割ワクチンの販売：タイプ別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの4価インフルエンザウイルス分割ワクチン 収益：タイプ別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカの4価インフルエンザウイルス分割ワクチン 市場規模：用途別
    • 中東, アフリカ ・ラテンアメリカの4価インフルエンザウイルス分割ワクチンの販売：用途別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの4価インフルエンザウイルス分割ワクチンの収益：用途別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカの4価インフルエンザウイルス分割ワクチンの販売：国別
    • 中東, アフリカ ・ラテンアメリカの4価インフルエンザウイルス分割ワクチンの収益：国別: 2018 VS 2022 VS 2029
    • 中東, アフリカ ・ラテンアメリカの4価インフルエンザウイルス分割ワクチンの収益：国別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの4価インフルエンザウイルス分割ワクチンの販売：国別 (2018-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第11章 企業プロファイル

  • Hualan Biological Engineering
  • ADIMMUNE Corporation
  • Jiangsu GDK Biotechnology
  • Shanghai Institute Of Biological Products
  • Changchun Lnstitute of Biological Products Co., Ltd.
  • Wuhan Institute of Biological Products Co., Ltd.
  • Sinovac Biotech
  • Chongqing Zhifei Biological Products
  • Sanofi Pasteur

第12章 業界チェーンと販売チャネルの分析

  • 4価インフルエンザウイルス分割ワクチン 業界チェーン分析
  • 4価インフルエンザウイルス分割ワクチン 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • 4価インフルエンザウイルス分割ワクチン 生産形態とプロセス
  • 4価インフルエンザウイルス分割ワクチン 販売およびマーケティング
    • 4価インフルエンザウイルス分割ワクチン 販売チャネルs
    • 4価インフルエンザウイルス分割ワクチン 卸業者
  • 4価インフルエンザウイルス分割ワクチン 顧客

第13章 市場動向

  • 4価インフルエンザウイルス分割ワクチン 業界動向
  • 4価インフルエンザウイルス分割ワクチン 市場の促進要因
  • 4価インフルエンザウイルス分割ワクチン 市場の課題
  • 4価インフルエンザウイルス分割ワクチン 市場の抑制要因

第14章 主な調査結果 世界の4価インフルエンザウイルス分割ワクチンの主な市場調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global Quadrivalent Influenza Virus Split Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of 0.5mL/Tube
  • Table 3. Major Manufacturers of Others
  • Table 4. Global Quadrivalent Influenza Virus Split Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 5. Global Quadrivalent Influenza Virus Split Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 6. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Region (2018-2023) & (US$ Million)
  • Table 7. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Region (2024-2029) & (US$ Million)
  • Table 8. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Region (2018-2023)
  • Table 9. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Region (2024-2029)
  • Table 10. Global Quadrivalent Influenza Virus Split Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 11. Global Quadrivalent Influenza Virus Split Vaccine Sales by Region (2018-2023) & (K Units)
  • Table 12. Global Quadrivalent Influenza Virus Split Vaccine Sales by Region (2024-2029) & (K Units)
  • Table 13. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Region (2018-2023)
  • Table 14. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Region (2024-2029)
  • Table 15. Global Quadrivalent Influenza Virus Split Vaccine Sales by Manufacturers (2018-2023) & (K Units)
  • Table 16. Global Quadrivalent Influenza Virus Split Vaccine Sales Share by Manufacturers (2018-2023)
  • Table 17. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Manufacturers (2018-2023) & (US$ Million)
  • Table 18. Global Quadrivalent Influenza Virus Split Vaccine Revenue Share by Manufacturers (2018-2023)
  • Table 19. Global Key Players of Quadrivalent Influenza Virus Split Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
  • Table 20. Quadrivalent Influenza Virus Split Vaccine Price by Manufacturers 2018-2023 (US$/Unit)
  • Table 21. Global Quadrivalent Influenza Virus Split Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 22. Global Quadrivalent Influenza Virus Split Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quadrivalent Influenza Virus Split Vaccine as of 2022)
  • Table 23. Global Key Manufacturers of Quadrivalent Influenza Virus Split Vaccine, Manufacturing Base Distribution and Headquarters
  • Table 24. Global Key Manufacturers of Quadrivalent Influenza Virus Split Vaccine, Product Offered and Application
  • Table 25. Global Key Manufacturers of Quadrivalent Influenza Virus Split Vaccine, Date of Enter into This Industry
  • Table 26. Mergers & Acquisitions, Expansion Plans
  • Table 27. Global Quadrivalent Influenza Virus Split Vaccine Sales by Type (2018-2023) & (K Units)
  • Table 28. Global Quadrivalent Influenza Virus Split Vaccine Sales by Type (2024-2029) & (K Units)
  • Table 29. Global Quadrivalent Influenza Virus Split Vaccine Sales Share by Type (2018-2023)
  • Table 30. Global Quadrivalent Influenza Virus Split Vaccine Sales Share by Type (2024-2029)
  • Table 31. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2018-2023) & (US$ Million)
  • Table 32. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2024-2029) & (US$ Million)
  • Table 33. Global Quadrivalent Influenza Virus Split Vaccine Revenue Share by Type (2018-2023)
  • Table 34. Global Quadrivalent Influenza Virus Split Vaccine Revenue Share by Type (2024-2029)
  • Table 35. Quadrivalent Influenza Virus Split Vaccine Price by Type (2018-2023) & (US$/Unit)
  • Table 36. Global Quadrivalent Influenza Virus Split Vaccine Price Forecast by Type (2024-2029) & (US$/Unit)
  • Table 37. Global Quadrivalent Influenza Virus Split Vaccine Sales by Application (2018-2023) & (K Units)
  • Table 38. Global Quadrivalent Influenza Virus Split Vaccine Sales by Application (2024-2029) & (K Units)
  • Table 39. Global Quadrivalent Influenza Virus Split Vaccine Sales Share by Application (2018-2023)
  • Table 40. Global Quadrivalent Influenza Virus Split Vaccine Sales Share by Application (2024-2029)
  • Table 41. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2018-2023) & (US$ Million)
  • Table 42. Global Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2024-2029) & (US$ Million)
  • Table 43. Global Quadrivalent Influenza Virus Split Vaccine Revenue Share by Application (2018-2023)
  • Table 44. Global Quadrivalent Influenza Virus Split Vaccine Revenue Share by Application (2024-2029)
  • Table 45. Quadrivalent Influenza Virus Split Vaccine Price by Application (2018-2023) & (US$/Unit)
  • Table 46. Global Quadrivalent Influenza Virus Split Vaccine Price Forecast by Application (2024-2029) & (US$/Unit)
  • Table 47. US & Canada Quadrivalent Influenza Virus Split Vaccine Sales by Type (2018-2023) & (K Units)
  • Table 48. US & Canada Quadrivalent Influenza Virus Split Vaccine Sales by Type (2024-2029) & (K Units)
  • Table 49. US & Canada Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2018-2023) & (US$ Million)
  • Table 50. US & Canada Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2024-2029) & (US$ Million)
  • Table 51. US & Canada Quadrivalent Influenza Virus Split Vaccine Sales by Application (2018-2023) & (K Units)
  • Table 52. US & Canada Quadrivalent Influenza Virus Split Vaccine Sales by Application (2024-2029) & (K Units)
  • Table 53. US & Canada Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2018-2023) & (US$ Million)
  • Table 54. US & Canada Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2024-2029) & (US$ Million)
  • Table 55. US & Canada Quadrivalent Influenza Virus Split Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 56. US & Canada Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2018-2023) & (US$ Million)
  • Table 57. US & Canada Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2024-2029) & (US$ Million)
  • Table 58. US & Canada Quadrivalent Influenza Virus Split Vaccine Sales by Country (2018-2023) & (K Units)
  • Table 59. US & Canada Quadrivalent Influenza Virus Split Vaccine Sales by Country (2024-2029) & (K Units)
  • Table 60. Europe Quadrivalent Influenza Virus Split Vaccine Sales by Type (2018-2023) & (K Units)
  • Table 61. Europe Quadrivalent Influenza Virus Split Vaccine Sales by Type (2024-2029) & (K Units)
  • Table 62. Europe Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2018-2023) & (US$ Million)
  • Table 63. Europe Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2024-2029) & (US$ Million)
  • Table 64. Europe Quadrivalent Influenza Virus Split Vaccine Sales by Application (2018-2023) & (K Units)
  • Table 65. Europe Quadrivalent Influenza Virus Split Vaccine Sales by Application (2024-2029) & (K Units)
  • Table 66. Europe Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2018-2023) & (US$ Million)
  • Table 67. Europe Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2024-2029) & (US$ Million)
  • Table 68. Europe Quadrivalent Influenza Virus Split Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 69. Europe Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2018-2023) & (US$ Million)
  • Table 70. Europe Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2024-2029) & (US$ Million)
  • Table 71. Europe Quadrivalent Influenza Virus Split Vaccine Sales by Country (2018-2023) & (K Units)
  • Table 72. Europe Quadrivalent Influenza Virus Split Vaccine Sales by Country (2024-2029) & (K Units)
  • Table 73. China Quadrivalent Influenza Virus Split Vaccine Sales by Type (2018-2023) & (K Units)
  • Table 74. China Quadrivalent Influenza Virus Split Vaccine Sales by Type (2024-2029) & (K Units)
  • Table 75. China Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2018-2023) & (US$ Million)
  • Table 76. China Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2024-2029) & (US$ Million)
  • Table 77. China Quadrivalent Influenza Virus Split Vaccine Sales by Application (2018-2023) & (K Units)
  • Table 78. China Quadrivalent Influenza Virus Split Vaccine Sales by Application (2024-2029) & (K Units)
  • Table 79. China Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2018-2023) & (US$ Million)
  • Table 80. China Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2024-2029) & (US$ Million)
  • Table 81. Asia Quadrivalent Influenza Virus Split Vaccine Sales by Type (2018-2023) & (K Units)
  • Table 82. Asia Quadrivalent Influenza Virus Split Vaccine Sales by Type (2024-2029) & (K Units)
  • Table 83. Asia Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2018-2023) & (US$ Million)
  • Table 84. Asia Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2024-2029) & (US$ Million)
  • Table 85. Asia Quadrivalent Influenza Virus Split Vaccine Sales by Application (2018-2023) & (K Units)
  • Table 86. Asia Quadrivalent Influenza Virus Split Vaccine Sales by Application (2024-2029) & (K Units)
  • Table 87. Asia Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2018-2023) & (US$ Million)
  • Table 88. Asia Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2024-2029) & (US$ Million)
  • Table 89. Asia Quadrivalent Influenza Virus Split Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 90. Asia Quadrivalent Influenza Virus Split Vaccine Revenue by Region (2018-2023) & (US$ Million)
  • Table 91. Asia Quadrivalent Influenza Virus Split Vaccine Revenue by Region (2024-2029) & (US$ Million)
  • Table 92. Asia Quadrivalent Influenza Virus Split Vaccine Sales by Region (2018-2023) & (K Units)
  • Table 93. Asia Quadrivalent Influenza Virus Split Vaccine Sales by Region (2024-2029) & (K Units)
  • Table 94. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Sales by Type (2018-2023) & (K Units)
  • Table 95. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Sales by Type (2024-2029) & (K Units)
  • Table 96. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2018-2023) & (US$ Million)
  • Table 97. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2024-2029) & (US$ Million)
  • Table 98. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Sales by Application (2018-2023) & (K Units)
  • Table 99. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Sales by Application (2024-2029) & (K Units)
  • Table 100. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2018-2023) & (US$ Million)
  • Table 101. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2024-2029) & (US$ Million)
  • Table 102. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 103. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2018-2023) & (US$ Million)
  • Table 104. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2024-2029) & (US$ Million)
  • Table 105. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Sales by Country (2018-2023) & (K Units)
  • Table 106. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Sales by Country (2024-2029) & (K Units)
  • Table 107. Hualan Biological Engineering Company Information
  • Table 108. Hualan Biological Engineering Description and Major Businesses
  • Table 109. Hualan Biological Engineering Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 110. Hualan Biological Engineering Quadrivalent Influenza Virus Split Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 111. Hualan Biological Engineering Recent Developments
  • Table 112. ADIMMUNE Corporation Company Information
  • Table 113. ADIMMUNE Corporation Description and Major Businesses
  • Table 114. ADIMMUNE Corporation Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 115. ADIMMUNE Corporation Quadrivalent Influenza Virus Split Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 116. ADIMMUNE Corporation Recent Developments
  • Table 117. Jiangsu GDK Biotechnology Company Information
  • Table 118. Jiangsu GDK Biotechnology Description and Major Businesses
  • Table 119. Jiangsu GDK Biotechnology Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 120. Jiangsu GDK Biotechnology Quadrivalent Influenza Virus Split Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 121. Jiangsu GDK Biotechnology Recent Developments
  • Table 122. Shanghai Institute Of Biological Products Company Information
  • Table 123. Shanghai Institute Of Biological Products Description and Major Businesses
  • Table 124. Shanghai Institute Of Biological Products Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 125. Shanghai Institute Of Biological Products Quadrivalent Influenza Virus Split Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 126. Shanghai Institute Of Biological Products Recent Developments
  • Table 127. Changchun Lnstitute of Biological Products Co., Ltd. Company Information
  • Table 128. Changchun Lnstitute of Biological Products Co., Ltd. Description and Major Businesses
  • Table 129. Changchun Lnstitute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 130. Changchun Lnstitute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 131. Changchun Lnstitute of Biological Products Co., Ltd. Recent Developments
  • Table 132. Wuhan Institute of Biological Products Co., Ltd. Company Information
  • Table 133. Wuhan Institute of Biological Products Co., Ltd. Description and Major Businesses
  • Table 134. Wuhan Institute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 135. Wuhan Institute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 136. Wuhan Institute of Biological Products Co., Ltd. Recent Developments
  • Table 137. Sinovac Biotech Company Information
  • Table 138. Sinovac Biotech Description and Major Businesses
  • Table 139. Sinovac Biotech Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 140. Sinovac Biotech Quadrivalent Influenza Virus Split Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 141. Sinovac Biotech Recent Developments
  • Table 142. Chongqing Zhifei Biological Products Company Information
  • Table 143. Chongqing Zhifei Biological Products Description and Major Businesses
  • Table 144. Chongqing Zhifei Biological Products Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 145. Chongqing Zhifei Biological Products Quadrivalent Influenza Virus Split Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 146. Chongqing Zhifei Biological Products Recent Developments
  • Table 147. Sanofi Pasteur Company Information
  • Table 148. Sanofi Pasteur Description and Major Businesses
  • Table 149. Sanofi Pasteur Quadrivalent Influenza Virus Split Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 150. Sanofi Pasteur Quadrivalent Influenza Virus Split Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 151. Sanofi Pasteur Recent Developments
  • Table 152. Key Raw Materials Lists
  • Table 153. Raw Materials Key Suppliers Lists
  • Table 154. Quadrivalent Influenza Virus Split Vaccine Distributors List
  • Table 155. Quadrivalent Influenza Virus Split Vaccine Customers List
  • Table 156. Quadrivalent Influenza Virus Split Vaccine Market Trends
  • Table 157. Quadrivalent Influenza Virus Split Vaccine Market Drivers
  • Table 158. Quadrivalent Influenza Virus Split Vaccine Market Challenges
  • Table 159. Quadrivalent Influenza Virus Split Vaccine Market Restraints
  • Table 160. Research Programs/Design for This Report
  • Table 161. Key Data Information from Secondary Sources
  • Table 162. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Quadrivalent Influenza Virus Split Vaccine Product Picture
  • Figure 2. Global Quadrivalent Influenza Virus Split Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global Quadrivalent Influenza Virus Split Vaccine Market Share by Type in 2022 & 2029
  • Figure 4. 0.5mL/Tube Product Picture
  • Figure 5. Others Product Picture
  • Figure 6. Global Quadrivalent Influenza Virus Split Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global Quadrivalent Influenza Virus Split Vaccine Market Share by Application in 2022 & 2029
  • Figure 8. Influenza A Virus Prevention
  • Figure 9. Influenza B Virus Prevention
  • Figure 10. Quadrivalent Influenza Virus Split Vaccine Report Years Considered
  • Figure 11. Global Quadrivalent Influenza Virus Split Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 12. Global Quadrivalent Influenza Virus Split Vaccine Revenue 2018-2029 (US$ Million)
  • Figure 13. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 14. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Region (2018-2029)
  • Figure 15. Global Quadrivalent Influenza Virus Split Vaccine Sales 2018-2029 ((K Units)
  • Figure 16. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Region (2018-2029)
  • Figure 17. US & Canada Quadrivalent Influenza Virus Split Vaccine Sales YoY (2018-2029) & (K Units)
  • Figure 18. US & Canada Quadrivalent Influenza Virus Split Vaccine Revenue YoY (2018-2029) & (US$ Million)
  • Figure 19. Europe Quadrivalent Influenza Virus Split Vaccine Sales YoY (2018-2029) & (K Units)
  • Figure 20. Europe Quadrivalent Influenza Virus Split Vaccine Revenue YoY (2018-2029) & (US$ Million)
  • Figure 21. China Quadrivalent Influenza Virus Split Vaccine Sales YoY (2018-2029) & (K Units)
  • Figure 22. China Quadrivalent Influenza Virus Split Vaccine Revenue YoY (2018-2029) & (US$ Million)
  • Figure 23. Asia (excluding China) Quadrivalent Influenza Virus Split Vaccine Sales YoY (2018-2029) & (K Units)
  • Figure 24. Asia (excluding China) Quadrivalent Influenza Virus Split Vaccine Revenue YoY (2018-2029) & (US$ Million)
  • Figure 25. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Sales YoY (2018-2029) & (K Units)
  • Figure 26. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Revenue YoY (2018-2029) & (US$ Million)
  • Figure 27. The Quadrivalent Influenza Virus Split Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
  • Figure 28. The Top 5 and 10 Largest Manufacturers of Quadrivalent Influenza Virus Split Vaccine in the World: Market Share by Quadrivalent Influenza Virus Split Vaccine Revenue in 2022
  • Figure 29. Global Quadrivalent Influenza Virus Split Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 30. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2018-2029)
  • Figure 31. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Type (2018-2029)
  • Figure 32. Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Application (2018-2029)
  • Figure 33. Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Application (2018-2029)
  • Figure 34. US & Canada Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2018-2029)
  • Figure 35. US & Canada Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Type (2018-2029)
  • Figure 36. US & Canada Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Application (2018-2029)
  • Figure 37. US & Canada Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Application (2018-2029)
  • Figure 38. US & Canada Quadrivalent Influenza Virus Split Vaccine Revenue Share by Country (2018-2029)
  • Figure 39. US & Canada Quadrivalent Influenza Virus Split Vaccine Sales Share by Country (2018-2029)
  • Figure 40. U.S. Quadrivalent Influenza Virus Split Vaccine Revenue (2018-2029) & (US$ Million)
  • Figure 41. Canada Quadrivalent Influenza Virus Split Vaccine Revenue (2018-2029) & (US$ Million)
  • Figure 42. Europe Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2018-2029)
  • Figure 43. Europe Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Type (2018-2029)
  • Figure 44. Europe Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Application (2018-2029)
  • Figure 45. Europe Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Application (2018-2029)
  • Figure 46. Europe Quadrivalent Influenza Virus Split Vaccine Revenue Share by Country (2018-2029)
  • Figure 47. Europe Quadrivalent Influenza Virus Split Vaccine Sales Share by Country (2018-2029)
  • Figure 48. Germany Quadrivalent Influenza Virus Split Vaccine Revenue (2018-2029) & (US$ Million)
  • Figure 49. France Quadrivalent Influenza Virus Split Vaccine Revenue (2018-2029) & (US$ Million)
  • Figure 50. U.K. Quadrivalent Influenza Virus Split Vaccine Revenue (2018-2029) & (US$ Million)
  • Figure 51. Italy Quadrivalent Influenza Virus Split Vaccine Revenue (2018-2029) & (US$ Million)
  • Figure 52. Russia Quadrivalent Influenza Virus Split Vaccine Revenue (2018-2029) & (US$ Million)
  • Figure 53. China Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2018-2029)
  • Figure 54. China Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Type (2018-2029)
  • Figure 55. China Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Application (2018-2029)
  • Figure 56. China Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Application (2018-2029)
  • Figure 57. Asia Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2018-2029)
  • Figure 58. Asia Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Type (2018-2029)
  • Figure 59. Asia Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Application (2018-2029)
  • Figure 60. Asia Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Application (2018-2029)
  • Figure 61. Asia Quadrivalent Influenza Virus Split Vaccine Revenue Share by Region (2018-2029)
  • Figure 62. Asia Quadrivalent Influenza Virus Split Vaccine Sales Share by Region (2018-2029)
  • Figure 63. Japan Quadrivalent Influenza Virus Split Vaccine Revenue (2018-2029) & (US$ Million)
  • Figure 64. South Korea Quadrivalent Influenza Virus Split Vaccine Revenue (2018-2029) & (US$ Million)
  • Figure 65. China Taiwan Quadrivalent Influenza Virus Split Vaccine Revenue (2018-2029) & (US$ Million)
  • Figure 66. Southeast Asia Quadrivalent Influenza Virus Split Vaccine Revenue (2018-2029) & (US$ Million)
  • Figure 67. India Quadrivalent Influenza Virus Split Vaccine Revenue (2018-2029) & (US$ Million)
  • Figure 68. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2018-2029)
  • Figure 69. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Type (2018-2029)
  • Figure 70. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Application (2018-2029)
  • Figure 71. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Application (2018-2029)
  • Figure 72. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Revenue Share by Country (2018-2029)
  • Figure 73. Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Sales Share by Country (2018-2029)
  • Figure 74. Brazil Quadrivalent Influenza Virus Split Vaccine Revenue (2018-2029) & (US$ Million)
  • Figure 75. Mexico Quadrivalent Influenza Virus Split Vaccine Revenue (2018-2029) & (US$ Million)
  • Figure 76. Turkey Quadrivalent Influenza Virus Split Vaccine Revenue (2018-2029) & (US$ Million)
  • Figure 77. Israel Quadrivalent Influenza Virus Split Vaccine Revenue (2018-2029) & (US$ Million)
  • Figure 78. GCC Countries Quadrivalent Influenza Virus Split Vaccine Revenue (2018-2029) & (US$ Million)
  • Figure 79. Quadrivalent Influenza Virus Split Vaccine Value Chain
  • Figure 80. Quadrivalent Influenza Virus Split Vaccine Production Process
  • Figure 81. Channels of Distribution
  • Figure 82. Distributors Profiles
  • Figure 83. Bottom-up and Top-down Approaches for This Report
  • Figure 84. Data Triangulation
  • Figure 85. Key Executives Interviewed
目次

This research report focuses on the Quadrivalent Influenza Virus Split Vaccine Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Quadrivalent Influenza Virus Split Vaccine Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Quadrivalent Influenza Virus Split Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 0.5mL/Tube
    • 1.2.3 Others
  • 1.3 Market by Application
    • 1.3.1 Global Quadrivalent Influenza Virus Split Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Influenza A Virus Prevention
    • 1.3.3 Influenza B Virus Prevention
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Quadrivalent Influenza Virus Split Vaccine Sales Estimates and Forecasts 2018-2029
  • 2.2 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Region
    • 2.2.1 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Region (2018-2023)
    • 2.2.3 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Region (2024-2029)
    • 2.2.4 Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Region (2018-2029)
  • 2.3 Global Quadrivalent Influenza Virus Split Vaccine Sales Estimates and Forecasts 2018-2029
  • 2.4 Global Quadrivalent Influenza Virus Split Vaccine Sales by Region
    • 2.4.1 Global Quadrivalent Influenza Virus Split Vaccine Sales by Region: 2018 VS 2022 VS 2029
    • 2.4.2 Global Quadrivalent Influenza Virus Split Vaccine Sales by Region (2018-2023)
    • 2.4.3 Global Quadrivalent Influenza Virus Split Vaccine Sales by Region (2024-2029)
    • 2.4.4 Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Region (2018-2029)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global Quadrivalent Influenza Virus Split Vaccine Sales by Manufacturers
    • 3.1.1 Global Quadrivalent Influenza Virus Split Vaccine Sales by Manufacturers (2018-2023)
    • 3.1.2 Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Manufacturers (2018-2023)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Quadrivalent Influenza Virus Split Vaccine in 2022
  • 3.2 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Manufacturers
    • 3.2.1 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Manufacturers (2018-2023)
    • 3.2.2 Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Manufacturers (2018-2023)
    • 3.2.3 Global Top 10 and Top 5 Companies by Quadrivalent Influenza Virus Split Vaccine Revenue in 2022
  • 3.3 Global Key Players of Quadrivalent Influenza Virus Split Vaccine, Industry Ranking, 2021 VS 2022 VS 2023
  • 3.4 Global Quadrivalent Influenza Virus Split Vaccine Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Quadrivalent Influenza Virus Split Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Quadrivalent Influenza Virus Split Vaccine, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Quadrivalent Influenza Virus Split Vaccine, Product Offered and Application
  • 3.8 Global Key Manufacturers of Quadrivalent Influenza Virus Split Vaccine, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Quadrivalent Influenza Virus Split Vaccine Sales by Type
    • 4.1.1 Global Quadrivalent Influenza Virus Split Vaccine Historical Sales by Type (2018-2023)
    • 4.1.2 Global Quadrivalent Influenza Virus Split Vaccine Forecasted Sales by Type (2024-2029)
    • 4.1.3 Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Type (2018-2029)
  • 4.2 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Type
    • 4.2.1 Global Quadrivalent Influenza Virus Split Vaccine Historical Revenue by Type (2018-2023)
    • 4.2.2 Global Quadrivalent Influenza Virus Split Vaccine Forecasted Revenue by Type (2024-2029)
    • 4.2.3 Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Type (2018-2029)
  • 4.3 Global Quadrivalent Influenza Virus Split Vaccine Price by Type
    • 4.3.1 Global Quadrivalent Influenza Virus Split Vaccine Price by Type (2018-2023)
    • 4.3.2 Global Quadrivalent Influenza Virus Split Vaccine Price Forecast by Type (2024-2029)

5 Market Size by Application

  • 5.1 Global Quadrivalent Influenza Virus Split Vaccine Sales by Application
    • 5.1.1 Global Quadrivalent Influenza Virus Split Vaccine Historical Sales by Application (2018-2023)
    • 5.1.2 Global Quadrivalent Influenza Virus Split Vaccine Forecasted Sales by Application (2024-2029)
    • 5.1.3 Global Quadrivalent Influenza Virus Split Vaccine Sales Market Share by Application (2018-2029)
  • 5.2 Global Quadrivalent Influenza Virus Split Vaccine Revenue by Application
    • 5.2.1 Global Quadrivalent Influenza Virus Split Vaccine Historical Revenue by Application (2018-2023)
    • 5.2.2 Global Quadrivalent Influenza Virus Split Vaccine Forecasted Revenue by Application (2024-2029)
    • 5.2.3 Global Quadrivalent Influenza Virus Split Vaccine Revenue Market Share by Application (2018-2029)
  • 5.3 Global Quadrivalent Influenza Virus Split Vaccine Price by Application
    • 5.3.1 Global Quadrivalent Influenza Virus Split Vaccine Price by Application (2018-2023)
    • 5.3.2 Global Quadrivalent Influenza Virus Split Vaccine Price Forecast by Application (2024-2029)

6 US & Canada

  • 6.1 US & Canada Quadrivalent Influenza Virus Split Vaccine Market Size by Type
    • 6.1.1 US & Canada Quadrivalent Influenza Virus Split Vaccine Sales by Type (2018-2029)
    • 6.1.2 US & Canada Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2018-2029)
  • 6.2 US & Canada Quadrivalent Influenza Virus Split Vaccine Market Size by Application
    • 6.2.1 US & Canada Quadrivalent Influenza Virus Split Vaccine Sales by Application (2018-2029)
    • 6.2.2 US & Canada Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2018-2029)
  • 6.3 US & Canada Quadrivalent Influenza Virus Split Vaccine Market Size by Country
    • 6.3.1 US & Canada Quadrivalent Influenza Virus Split Vaccine Revenue by Country: 2018 VS 2022 VS 2029
    • 6.3.2 US & Canada Quadrivalent Influenza Virus Split Vaccine Sales by Country (2018-2029)
    • 6.3.3 US & Canada Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2018-2029)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Quadrivalent Influenza Virus Split Vaccine Market Size by Type
    • 7.1.1 Europe Quadrivalent Influenza Virus Split Vaccine Sales by Type (2018-2029)
    • 7.1.2 Europe Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2018-2029)
  • 7.2 Europe Quadrivalent Influenza Virus Split Vaccine Market Size by Application
    • 7.2.1 Europe Quadrivalent Influenza Virus Split Vaccine Sales by Application (2018-2029)
    • 7.2.2 Europe Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2018-2029)
  • 7.3 Europe Quadrivalent Influenza Virus Split Vaccine Market Size by Country
    • 7.3.1 Europe Quadrivalent Influenza Virus Split Vaccine Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 Europe Quadrivalent Influenza Virus Split Vaccine Sales by Country (2018-2029)
    • 7.3.3 Europe Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2018-2029)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China Quadrivalent Influenza Virus Split Vaccine Market Size
    • 8.1.1 China Quadrivalent Influenza Virus Split Vaccine Sales (2018-2029)
    • 8.1.2 China Quadrivalent Influenza Virus Split Vaccine Revenue (2018-2029)
  • 8.2 China Quadrivalent Influenza Virus Split Vaccine Market Size by Application
    • 8.2.1 China Quadrivalent Influenza Virus Split Vaccine Sales by Application (2018-2029)
    • 8.2.2 China Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Quadrivalent Influenza Virus Split Vaccine Market Size by Type
    • 9.1.1 Asia Quadrivalent Influenza Virus Split Vaccine Sales by Type (2018-2029)
    • 9.1.2 Asia Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2018-2029)
  • 9.2 Asia Quadrivalent Influenza Virus Split Vaccine Market Size by Application
    • 9.2.1 Asia Quadrivalent Influenza Virus Split Vaccine Sales by Application (2018-2029)
    • 9.2.2 Asia Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2018-2029)
  • 9.3 Asia Quadrivalent Influenza Virus Split Vaccine Sales by Region
    • 9.3.1 Asia Quadrivalent Influenza Virus Split Vaccine Revenue by Region: 2018 VS 2022 VS 2029
    • 9.3.2 Asia Quadrivalent Influenza Virus Split Vaccine Revenue by Region (2018-2029)
    • 9.3.3 Asia Quadrivalent Influenza Virus Split Vaccine Sales by Region (2018-2029)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Sales by Type (2018-2029)
    • 10.1.2 Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Revenue by Type (2018-2029)
  • 10.2 Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Sales by Application (2018-2029)
    • 10.2.2 Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Revenue by Application (2018-2029)
  • 10.3 Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Sales by Country
    • 10.3.1 Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Revenue by Country: 2018 VS 2022 VS 2029
    • 10.3.2 Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Revenue by Country (2018-2029)
    • 10.3.3 Middle East, Africa and Latin America Quadrivalent Influenza Virus Split Vaccine Sales by Country (2018-2029)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 Hualan Biological Engineering
    • 11.1.1 Hualan Biological Engineering Company Information
    • 11.1.2 Hualan Biological Engineering Overview
    • 11.1.3 Hualan Biological Engineering Quadrivalent Influenza Virus Split Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.1.4 Hualan Biological Engineering Quadrivalent Influenza Virus Split Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Hualan Biological Engineering Recent Developments
  • 11.2 ADIMMUNE Corporation
    • 11.2.1 ADIMMUNE Corporation Company Information
    • 11.2.2 ADIMMUNE Corporation Overview
    • 11.2.3 ADIMMUNE Corporation Quadrivalent Influenza Virus Split Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.2.4 ADIMMUNE Corporation Quadrivalent Influenza Virus Split Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 ADIMMUNE Corporation Recent Developments
  • 11.3 Jiangsu GDK Biotechnology
    • 11.3.1 Jiangsu GDK Biotechnology Company Information
    • 11.3.2 Jiangsu GDK Biotechnology Overview
    • 11.3.3 Jiangsu GDK Biotechnology Quadrivalent Influenza Virus Split Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.3.4 Jiangsu GDK Biotechnology Quadrivalent Influenza Virus Split Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Jiangsu GDK Biotechnology Recent Developments
  • 11.4 Shanghai Institute Of Biological Products
    • 11.4.1 Shanghai Institute Of Biological Products Company Information
    • 11.4.2 Shanghai Institute Of Biological Products Overview
    • 11.4.3 Shanghai Institute Of Biological Products Quadrivalent Influenza Virus Split Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.4.4 Shanghai Institute Of Biological Products Quadrivalent Influenza Virus Split Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Shanghai Institute Of Biological Products Recent Developments
  • 11.5 Changchun Lnstitute of Biological Products Co., Ltd.
    • 11.5.1 Changchun Lnstitute of Biological Products Co., Ltd. Company Information
    • 11.5.2 Changchun Lnstitute of Biological Products Co., Ltd. Overview
    • 11.5.3 Changchun Lnstitute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.5.4 Changchun Lnstitute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Changchun Lnstitute of Biological Products Co., Ltd. Recent Developments
  • 11.6 Wuhan Institute of Biological Products Co., Ltd.
    • 11.6.1 Wuhan Institute of Biological Products Co., Ltd. Company Information
    • 11.6.2 Wuhan Institute of Biological Products Co., Ltd. Overview
    • 11.6.3 Wuhan Institute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.6.4 Wuhan Institute of Biological Products Co., Ltd. Quadrivalent Influenza Virus Split Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Wuhan Institute of Biological Products Co., Ltd. Recent Developments
  • 11.7 Sinovac Biotech
    • 11.7.1 Sinovac Biotech Company Information
    • 11.7.2 Sinovac Biotech Overview
    • 11.7.3 Sinovac Biotech Quadrivalent Influenza Virus Split Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.7.4 Sinovac Biotech Quadrivalent Influenza Virus Split Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Sinovac Biotech Recent Developments
  • 11.8 Chongqing Zhifei Biological Products
    • 11.8.1 Chongqing Zhifei Biological Products Company Information
    • 11.8.2 Chongqing Zhifei Biological Products Overview
    • 11.8.3 Chongqing Zhifei Biological Products Quadrivalent Influenza Virus Split Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.8.4 Chongqing Zhifei Biological Products Quadrivalent Influenza Virus Split Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Chongqing Zhifei Biological Products Recent Developments
  • 11.9 Sanofi Pasteur
    • 11.9.1 Sanofi Pasteur Company Information
    • 11.9.2 Sanofi Pasteur Overview
    • 11.9.3 Sanofi Pasteur Quadrivalent Influenza Virus Split Vaccine Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.9.4 Sanofi Pasteur Quadrivalent Influenza Virus Split Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Sanofi Pasteur Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Quadrivalent Influenza Virus Split Vaccine Industry Chain Analysis
  • 12.2 Quadrivalent Influenza Virus Split Vaccine Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Quadrivalent Influenza Virus Split Vaccine Production Mode & Process
  • 12.4 Quadrivalent Influenza Virus Split Vaccine Sales and Marketing
    • 12.4.1 Quadrivalent Influenza Virus Split Vaccine Sales Channels
    • 12.4.2 Quadrivalent Influenza Virus Split Vaccine Distributors
  • 12.5 Quadrivalent Influenza Virus Split Vaccine Customers

13 Market Dynamics

  • 13.1 Quadrivalent Influenza Virus Split Vaccine Industry Trends
  • 13.2 Quadrivalent Influenza Virus Split Vaccine Market Drivers
  • 13.3 Quadrivalent Influenza Virus Split Vaccine Market Challenges
  • 13.4 Quadrivalent Influenza Virus Split Vaccine Market Restraints

14 Key Findings in The Global Quadrivalent Influenza Virus Split Vaccine Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer